Publication | Open Access

Prevention of Bone Metastases in Patients with High-risk Nonmetastatic Prostate Cancer Treated with Zoledronic Acid: Efficacy and Safety Results of the Zometa European Study (ZEUS)

Zoledronic AcidUrologyGenitourinary CancerMedicineCancer ManagementZometa European StudySafety ResultsProstatic DiseaseOncologyRadiation OncologyOsteoporosis